Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Antiglaucoma Drugs Market Global Briefing 2017

Antiglaucoma Drugs Market Global Briefing 2017

From $1,000.00

Including: Prostaglandins, Beta-Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Parasympathomimetics, Epinephrines, Hyperosmotic Agents, And Combination Glaucoma Drugs.
Covering: Alcon, Allergan, Pfizer Inc., Akorn Inc., Bayer


Clear selection
SKU: 2266. Category: .
Description

Antiglaucoma Drugs Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.

Description

The Antiglaucoma Drugs Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The antiglaucoma drugs market is one of the segments in the ophthalmology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the antiglaucoma drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the antiglaucoma drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the antiglaucoma drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Prostaglandins, Beta-blockers, Alpha-adrenergic agonists, Carbonic anhydrase inhibitors, Parasympathomimetics, epinephrines, Hyperosmotic agents, and combination glaucoma drugs.

Companies Mentioned: Alcon, Allergan, Pfizer Inc., Akorn Inc., Bayer.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Dry Eye Medication Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Antiglaucoma Drugs Market Characteristics
3. Antiglaucoma Drugs Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Antiglaucoma Drugs Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Antiglaucoma Drugs Market Geography Split
6. Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
7. Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2016, By Country
8. Antiglaucoma Drugs Market Segmentation
9. Antiglaucoma Drugs Competitive Landscape
Alcon
Allergan
Pfizer Inc.
Akorn Inc.
Bayer
10. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market
11. Antiglaucoma Drugs Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Antiglaucoma Drugs Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Antiglaucoma Drugs Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Antiglaucoma Drugs Market, Split By Region, 2016, $ Billion
Table 4: Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
Table 5: Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2016, By Country
Table 6: Global Antiglaucoma Drugs Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Antiglaucoma Drugs Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Antiglaucoma Drugs Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Antiglaucoma Drugs Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Antiglaucoma Drugs Market, Split By Region, 2016, $ Billion
Figure 4: Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
Figure 5: Antiglaucoma Drugs Market As A Proportion of Ophthalmology Drugs Market, 2020, By Country
Figure 6: Global Antiglaucoma Drugs Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Antiglaucoma Drugs Market, Split By Segments, 2016, $ Billion
Executive Summary
The antiglaucoma drugs market cover drugs that treat conditions that affect eyes. These conditions include open-angle glaucoma, angle-closure glaucoma, normal-tension glaucoma, congenital glaucoma, and other types of glaucoma. Based on therapeutic type, the market is segmented into: Prostaglandins, Beta-blockers, Alpha-adrenergic agonists, Carbonic anhydrase inhibitors, Parasympathomimetics, epinephrines, Hyperosmotic agents, and combination glaucoma drugs.

The global antiglaucoma drugs market was estimated to be around $6.9 billion as of 2016. The global antiglaucoma drugs made up around 7% of the overall ophthalmology drugs market in 2016. The antiglaucoma drugs market was the largest market in the global ophthalmology drugs market in 2016.

Development Of Combination Therapies
Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma and ocular hypertension.

Strategic Acquisitions
Acquisition of small and mid-size companies by the major competitors to expand their business operations and also to strengthen their market position is one of the trend in the market. For instance, in September 2016, Allergan acquired ForSight Vision5 for $95 million. It is an early stage clinical gene therapy company that engages in the R&D of medications for the treatment of Glaucoma
Get Customized Report
Please fill in your details. Our team will get back to you